Consistent with these findings, we show that treatment of the ER-negative, basal-like human breast cancer cell line MDA-MB-231 with a gamma-secretase inhibitor reduces intracellular NOTCH1 and NANOG protein levels. This evidence concerns the gene NOTCH1 and breast carcinoma.